Papers to Appear in Forthcoming Issues

Enhancement of T-Cell-Mediated Arthritis in Mice by Treatment with a Monoclonal Antibody against Interleukin-4. Shin Yoshino and Junko Yoshino. (Received 2/3/98; accepted 3/25/98.) tic Cells Internalize Vaccine Adjuvant after Intramuscular Injection. Marc Dupuis, Thomas J. Murphy, Deborah Higgins, Mildred Ugozzoli, Gary van Nest, Gary Ott, and Donald M. McDonald. (Received 9/12/97; accepted 3/23/98.) logical and Pathological Consequences of Mutations in both Fas and Fas Ligand. Jory P. Weintraub, Virginia Godfrey, P. Anne Wolthusen, Robert L. Cheek, Robert A. Eisenberg, and Philip L. Cohen. (Received 11/3/97; accepted 3/24/98.) f Nitric Oxide in Depressed Lymphoproliferative Responses and Altered Cytokine Production Following Thermal Injury in Rats. Isabelle Masson, Jacques Mathieu, Xavier-Bernard Nolland, Martine De Sousa, Brigitte Chanaud, Suzanne Strazlko, Yves Chancerelle, Jean-François Kergonou, Jean-Paul Giroud, and Irene Florentin. (Received 4/14/97; accepted 3/31/98.) egulation of Fas-Associated Phosphatase-1 (FAP-1) in Interleukin-2-Activated T Cells. Yan-Wen Zhou, Yoshihiro Komada, Hiroto Inaba, Eiichi Azuma, and Minoru Sakurai. (Received 12/31/97; accepted 3/31/98.) Dendritic Cells, Pulsed with either Melanoma Tumor Cell Lysates or the gp100 Peptide(280–288), Induced Pairs of T-Cell Cultures with Similar Phenotype and Lytic Activity. Zeinab Abdel-Wahab, Pierre DeMatos, Dina Hester, Xiang Da Dong, and Hilliard F. Seigler. (Received 12/18/97; accepted 3/31/98.) l Agonism Elicits an Enduring Phase of T-Cell-Mediated Antigen Presentation. Mark D. Mannie, Gregory A. White, John P. Nardella, Daniel K. Davidian, and Paula Y. Arnold. (Received 8/28/97; accepted 4/1/98.)